Randi J Hagerman Selected Research

Tremor (Tremors)

1/2021	Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.
5/2020	Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series.
4/2014	Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.
3/2014	Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.
10/2006	Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
2/2006	Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randi J Hagerman Research Topics

Disease

57	Fragile X Tremor Ataxia Syndrome 03/2024 - 01/2004
35	Fragile X Syndrome (Martin Bell Syndrome) 11/2022 - 01/2004
35	Intellectual Disability (Idiocy) 09/2021 - 12/2002
11	Autistic Disorder (Autism) 05/2021 - 02/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2021 - 01/2007
6	Cognitive Dysfunction 01/2022 - 10/2003
6	Tremor (Tremors) 01/2021 - 02/2006
6	Autism Spectrum Disorder 12/2020 - 04/2009
4	Atrophy 01/2023 - 02/2006
4	Neurodevelopmental Disorders 01/2022 - 12/2004
4	Ataxia (Dyssynergia) 01/2021 - 02/2006
3	Leukoencephalopathies 01/2021 - 02/2006
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 01/2023
2	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 01/2023
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 06/2020
2	Disease Progression 01/2021 - 06/2011
2	Primary Ovarian Insufficiency 01/2021 - 01/2020
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2019
2	Obesity 11/2019 - 11/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 05/2019 - 02/2006
2	Seizures (Absence Seizure) 01/2018 - 01/2009
2	Mental Disorders (Mental Disorder) 01/2018 - 11/2005
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 08/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 11/2016 - 12/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2014 - 03/2014
2	Parkinsonian Disorders (Parkinsonism) 04/2014 - 10/2006
2	Movement Disorders (Movement Disorder) 10/2006 - 01/2003
1	Clinical Deterioration 05/2020
1	Inflammation (Inflammations) 01/2020
1	Glucose Intolerance 11/2019
1	Nervous System Trauma 05/2019
1	Flatfoot (Flat Feet) 01/2018
1	Hallucinations (Hallucination) 01/2018
1	Neurologic Gait Disorders (Gait, Hemiplegic) 01/2018
1	Dementia (Dementias) 11/2016
1	Hypothyroidism 11/2016
1	Hypertension (High Blood Pressure) 11/2016
1	Hyperlipidemias (Hyperlipidemia) 11/2016

Drug/Important Bio-Agent (IBA)

28	Messenger RNA (mRNA)IBA 03/2024 - 01/2003
20	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2003
13	5' Untranslated Regions (5' UTR)IBA 09/2021 - 12/2002
8	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2006
8	Fragile X Mental Retardation ProteinIBA 12/2020 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2008
6	IronIBA 01/2023 - 08/2013
5	CytosineIBA 01/2023 - 01/2004
5	GuanineIBA 01/2023 - 01/2004
4	gamma-Aminobutyric Acid (GABA)IBA 05/2019 - 09/2012
4	Sertraline (Zoloft)FDA LinkGeneric 01/2019 - 01/2012
4	Metabotropic Glutamate 5 ReceptorIBA 01/2018 - 01/2009
4	Memantine (Namenda)FDA Link 02/2016 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 07/2007
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 10/2016
3	ganaxoloneIBA 08/2017 - 01/2015
3	ElementsIBA 07/2015 - 04/2013
3	Minocycline (Cyclops)FDA LinkGeneric 08/2013 - 09/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
2	ProteomeIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 11/2019 - 01/2019
2	Pregnanolone (Allopregnanolone)IBA 05/2019 - 01/2015
2	NeurosteroidsIBA 05/2019 - 01/2016
2	mavoglurantIBA 01/2019 - 01/2011
2	Serotonin (5 Hydroxytryptamine)IBA 06/2017 - 11/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2014 - 03/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2014 - 05/2014
2	Lamin Type A (Lamin A)IBA 01/2010 - 10/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	Glial Fibrillary Acidic ProteinIBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	Aldehyde DehydrogenaseIBA 12/2023
1	CytidineIBA 01/2023
1	oleylamide (oleamide)IBA 01/2023
1	messenger ribonucleoproteinIBA 11/2022
1	Serine (L-Serine)FDA Link 05/2021
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 05/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	UbiquitinIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	AntioxidantsIBA 01/2021
1	sulforaphaneIBA 01/2021
1	PhytochemicalsIBA 01/2021
1	Patched-1 ReceptorIBA 12/2020
1	TenascinIBA 01/2020
1	phosphoserine aminotransferase (phosphoserine transaminase)IBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	BiguanidesIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	2- chloro- 4- (1- (4- fluorophenyl)- 2,5- dimethyl- 1H- imidazol- 4- ylethynyl)pyridineIBA 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017
1	Opioid Analgesics (Opioids)IBA 11/2016
1	BenzodiazepinesIBA 11/2016
1	N-Methylaspartate (NMDA)IBA 02/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016

Therapy/Procedure

5	Therapeutics 02/2016 - 10/2006
2	Precision Medicine 12/2022 - 05/2019
2	General Anesthesia 05/2020 - 11/2016